Navigation Links
Early HIV Drug Therapy Protects Sex Partners From Virus
Date:5/13/2011

By Steven Reinberg
HealthDay Reporter

THURSDAY, May 12 (HealthDay News) -- People with HIV can reduce the risk of infecting their sex partners by more than 90 percent if they start treatment with antiretroviral drugs when their immune system is still relatively healthy, researchers announced Thursday.

The study, which included 1,763 mostly heterosexual couples from nine countries, was supposed to last until 2015, but the results were released early because of the significance of the findings. The research confirmed a belief held by many scientists and physicians -- that starting drug therapy early can help to limit rates of transmission of the virus that causes AIDS.

"We set out to prove that if you took earlier therapy you could benefit your own health and you could prevent the transmission of HIV," said lead researcher Dr. Myron Cohen, director of the Institute for Global Health and Infectious Diseases at the University of North Carolina at Chapel Hill.

"Both of those hypotheses were realized," he said.

The study, which started in 2005, randomly assigned the couples to two treatment groups: In the first group the HIV-infected individual began taking a combination of three antiretroviral drugs immediately. In the second group, the HIV-positive person delayed drug therapy until their CD4 T-cell count -- a blood test that measures immune system health -- either dropped below 250 or an AIDS-related illness (such as pneumocystis pneumonia) set in.

Both groups also received HIV care, which included counseling on safe sex, free condoms, treatment for sexually transmitted infections, regular HIV testing and evaluation, and treatment for any HIV-related complications.

The trial was conducted at 13 sites in nine countries including the United States, Botswana, Brazil, India, Kenya, Malawi, South Africa, Thailand and Zimbabwe.

In looking over the preliminary findings, the data and safety monitor
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Minnesota Department of Health Report: Nearly 6,000 Hospitalizations for COPD in 2007
2. Moms Lifestyle in Early Pregnancy Affects Babys Size
3. Early life stress may predict cardiovascular disease
4. MDS Announces Agreements to Divest MDS Pharma Services Early Stage Business
5. Alzheimers Association Applauds Social Security Administration for Adding Early-Onset Alzheimers to Its Compassionate Allowances Initiative
6. Alzheimers Foundation of America Applauds Social Security for Speeding Disability Benefits for Early-Onset Alzheimers Disease
7. JCI online early table of contents: Feb. 15, 2010
8. 29 Clear Channel stations Nationwide Raise Nearly $2.8 Million to Help Save the Lives of Kids Fighting Cancer and Other Deadly Diseases
9. Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer
10. Early On, Hormone Therapy May Raise Womens Heart Risks
11. FriendsofWater.com Responds to the National Acadamy of Sciences Report that Millions of Americans Get Sick Yearly from Contaminated Water
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Early HIV Drug Therapy Protects Sex Partners From Virus 
(Date:8/31/2014)... CA (PRWEB) August 31, 2014 Kicking ... kicking coach Matt Nelson of Matt Nelson Kicking Academy ... business, and on being a National Camp Series (NCS) ... of HustedKicking.com. , "Matt Nelson is another high quality ... many attributes to coaching. He is an outstanding ...
(Date:8/31/2014)... August 31, 2014 This September, ... California State Library, celebrates 30 years of changing ... Since its inception, California’s Library Literacy Services has ... learn to read and write. , To mark ... the state is launching a month-long awareness campaign ...
(Date:8/31/2014)... 2014 With the NCAA set to ... hosted an interview with Yale University Associate Athletic Director ... Yale’s approach to ensuring student-athlete experience that is consistent ... highlighted a number of key factors that contribute to ... critical factor in creating this culture seems simple at ...
(Date:8/31/2014)... 31 August 2014: Renal denervation seems to be more ... hypertension when it includes accessory renal arteries, according to ... Schmiedel from Germany. , Dr Schmiedel said: "More than ... is defined as blood pressure (BP) greater than 140/90 ... hypertension (rHTN) and are unable to reduce BP below ...
(Date:8/31/2014)... Barcelona, Spain Sunday 31 August 2014: Drinking tea ... 131 000 people presented at ESC Congress today by ... "If you have to choose between tea or coffee ... are important components of our way of life. Their ... the past with sometimes divergent results. We investigated the ...
Breaking Medicine News(10 mins):Health News:MichaelHusted.com Features an Interview with Matt Nelson of Matt Nelson Kicking Academy on His Role as a Kicking Coach and on Becoming a National Camp Series Associate 2Health News:MichaelHusted.com Features an Interview with Matt Nelson of Matt Nelson Kicking Academy on His Role as a Kicking Coach and on Becoming a National Camp Series Associate 3Health News:California Library Literacy Services Celebrates 30th Anniversary 2Health News:California Library Literacy Services Celebrates 30th Anniversary 3Health News:Yale University’s Steve Conn Discusses NCAA Football, Student-Athlete Experience, & Social Media SCI Talk Interview 2Health News:Yale University’s Steve Conn Discusses NCAA Football, Student-Athlete Experience, & Social Media SCI Talk Interview 3Health News:Renal denervation more successful when it includes accessory arteries 2Health News:Drinking tea reduces non-CV mortality by 24 percent 2Health News:Drinking tea reduces non-CV mortality by 24 percent 3
... ARLINGTON, Va., Nov. 16 Acknowledging that their results ... in the International Journal of Andrology nevertheless attempt to link ... to maternal exposure to phthalates. The researchers, led by ... previous, and much publicized, study of phthalate exposure to evaluate ...
... , SOUTH SAN FRANCISCO, Calif., Nov. 15 ... Company will hold a teleconference and webcast at 8:00 a.m. Eastern ... Phase 3 SPEAR (Study of Picoplatin Efficacy After Relapse) trial of ... Conference Call and Webcast Information , To participate ...
... 15 The World Champion New York Yankees ... at New York Blood Center,s (NYBC) Biennial Chairman,s Dinner this ... The event is chaired by William J. Mullaney, MetLife ... the opportunity to honor these two outstanding supporting organizations as ...
... ... its intention to begin the drug registration process in Brazil and Colombia for its ... United States for the treatment of moderate to severe (Stage 2) chronic pain. ... Plantation, FL (Vocus) ...
... , ... from the RecordAF,registry (REgistry on Cardiac rhythm disORDers assessing ... Sessions of the,American Heart Association, show that in recently ... rhythm-control strategy,provides better short term control of the arrhythmia ...
... when new lead is needed in heart devices, ... -- Replacing or adding wiring increases the risk ... replace a pacemaker or other heart rhythm-stabilizing device, ... complication rates among patients enrolled in the REPLACE ...
Cached Medicine News:Health News:Swan Study Authors Note Results 'Not Straightforward' 2Health News:Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Results of Pivotal Phase 3 SPEAR Trial in Small Cell Lung Cancer 2Health News:World Champion New York Yankees, BNY Mellon to be Honored as New York Blood Center 'Champions of Life' 2Health News:Nutra Pharma Announces Plans to Begin Drug Registration Process in South America for its Over-the-Counter Pain Reliever 2Health News:Nutra Pharma Announces Plans to Begin Drug Registration Process in South America for its Over-the-Counter Pain Reliever 3Health News:Nutra Pharma Announces Plans to Begin Drug Registration Process in South America for its Over-the-Counter Pain Reliever 4Health News:First Global Atrial Fibrillation Registry, RecordAF, Shows Rhythm-Control Strategy With Current Therapies Achieves Improved Disease Control but not Clinical Outcomes 2Health News:First Global Atrial Fibrillation Registry, RecordAF, Shows Rhythm-Control Strategy With Current Therapies Achieves Improved Disease Control but not Clinical Outcomes 3Health News:First Global Atrial Fibrillation Registry, RecordAF, Shows Rhythm-Control Strategy With Current Therapies Achieves Improved Disease Control but not Clinical Outcomes 4Health News:First Global Atrial Fibrillation Registry, RecordAF, Shows Rhythm-Control Strategy With Current Therapies Achieves Improved Disease Control but not Clinical Outcomes 5
(Date:8/29/2014)... N.C. , Aug. 29, 2014 The ... of regulatory and marketplace changes. CI leaders who adjust ... In a new Best Practices, LLC study ... of actionable insights, including: - Use secondary ... than primary research - Internal staff who ...
(Date:8/29/2014)... , Aug. 29, 2014 Pomerantz LLP has ... or the "Company") (NASDAQ: EDAP ) and ... United States District Court, Southern District of ... on behalf of a class consisting of all persons ... 2013 and July 30, 2014, inclusive (the "Class Period"). This ...
(Date:8/29/2014)...   Mast Therapeutics, Inc. (NYSE MKT: ... Santosh Vetticaden, Chief Medical Officer and Senior Vice ... reasons, in mid-September.  Edwin L. Parsley , ... which Mast acquired earlier this year, will assume ... Chief Medical Officer.  Dr. Parsley previously was with ...
Breaking Medicine Technology:Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4
... Calif., April 8, 2011 Amgen (NASDAQ: ... the expansion of its operations in Brazil, including the ... has also agreed to reacquire rights in Brazil to ... acquired by Hypermarcas). Together, these transactions will provide Amgen ...
... the leading health care supply contracting company, announced today ... to its portfolio of agreements for Cardiac Rhythm Management ... leading provider of medical devices which treat cardiac, neurological ... portfolio of arrhythmia management products, including pacemakers, implantable cardioverter ...
Cached Medicine Technology:Amgen Establishes Commercial Operations in Brazil 2Amgen Establishes Commercial Operations in Brazil 3Amgen Establishes Commercial Operations in Brazil 4Novation Announces the Addition of St. Jude Medical to the Cardiac Rhythm Management Products Portfolio 2
Comfor™ Cast Boot - Rocker Sole - Closed Toe...
The Multi-Purpose Medical-Surgical Shoe...
... assay for the qualitative and ... to Gliadin in human serum. ... be used as an aid ... disorders, mainly Coeliac Disease. This ...
... For use as a non-reactive quality assurance reagent ... Toxoplasma gondii (TOXO IgG and TOXO IgM), IgG ... and rubella IgM), IgG and IgM antibodies to ... IgM antibodies to herpes simplex virus types 1 ...
Medicine Products: